World's Best Scientists 2026 revealed!
Nicholas Lintzeris

Nicholas Lintzeris

D-Index & Metrics

Social Sciences and Humanities

D-Index
53
Citations
10420
World Ranking
2311
National Ranking
164

Nicholas Lintzeris publication distribution in Social Sciences and Humanities in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Social Sciences and Humanities in 2026. The highlighted bar marks where Nicholas Lintzeris sits on this spectrum.

44–53 publications: 28 scientists 54–63 publications: 61 scientists 64–73 publications: 161 scientists 74–83 publications: 225 scientists 84–93 publications: 301 scientists 94–103 publications: 390 scientists 104–113 publications: 406 scientists 114–123 publications: 474 scientists 124–133 publications: 453 scientists 134–143 publications: 434 scientists 144–153 publications: 407 scientists 154–163 publications: 411 scientists 164–173 publications: 391 scientists 174–183 publications: 313 scientists 184–193 publications: 319 scientists 194–203 publications: 304 scientists 204–213 publications: 285 scientists 214–223 publications: 246 scientists 224–233 publications: 213 scientists 234–243 publications: 170 scientists 244–253 publications: 167 scientists 254–263 publications: 162 scientists 264–273 publications: 138 scientists 274–283 publications: 138 scientists 284–293 publications: 113 scientists 294–303 publications: 106 scientists 304–313 publications: 95 scientists 314–323 publications: 101 scientists 324–333 publications: 81 scientists 334–343 publications: 69 scientists 344–353 publications: 56 scientists 354–363 publications: 36 scientists 364–373 publications: 42 scientists 374–383 publications: 41 scientists 384–393 publications: 44 scientists 394–403 publications: 27 scientists 404–413 publications: 30 scientists 414–423 publications: 20 scientists 424–433 publications: 29 scientists 434–443 publications: 29 scientists 444–453 publications: 25 scientists 454–463 publications: 19 scientists 464–473 publications: 21 scientists 474–483 publications: 11 scientists 484–493 publications: 17 scientists 494–503 publications: 7 scientists 504–513 publications: 6 scientists 514–523 publications: 12 scientists 524–533 publications: 10 scientists 534–543 publications: 7 scientists 544–553 publications: 6 scientists 554–563 publications: 12 scientists 564–569 publications: 8 scientists 570+ publications: 100 scientists
44 publications 570+

This scientist: 255 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 570 publications or more.

Nicholas Lintzeris D-index placement in Social Sciences and Humanities in 2026

The chart shows the D-index (discipline H-index) distribution of Social Sciences and Humanities scientists ranked by Research.com in 2026. The highlighted bar marks where Nicholas Lintzeris sits on this spectrum.

30 D-Index: 177 scientists 31 D-Index: 210 scientists 32 D-Index: 222 scientists 33 D-Index: 188 scientists 34 D-Index: 181 scientists 35 D-Index: 243 scientists 36 D-Index: 261 scientists 37 D-Index: 272 scientists 38 D-Index: 278 scientists 39 D-Index: 300 scientists 40 D-Index: 297 scientists 41 D-Index: 308 scientists 42 D-Index: 313 scientists 43 D-Index: 300 scientists 44 D-Index: 269 scientists 45 D-Index: 260 scientists 46 D-Index: 228 scientists 47 D-Index: 251 scientists 48 D-Index: 203 scientists 49 D-Index: 186 scientists 50 D-Index: 187 scientists 51 D-Index: 166 scientists 52 D-Index: 138 scientists 53 D-Index: 141 scientists 54 D-Index: 131 scientists 55 D-Index: 137 scientists 56 D-Index: 109 scientists 57 D-Index: 129 scientists 58 D-Index: 95 scientists 59 D-Index: 105 scientists 60 D-Index: 106 scientists 61 D-Index: 86 scientists 62 D-Index: 94 scientists 63 D-Index: 77 scientists 64 D-Index: 79 scientists 65 D-Index: 59 scientists 66 D-Index: 68 scientists 67 D-Index: 51 scientists 68 D-Index: 49 scientists 69 D-Index: 40 scientists 70 D-Index: 43 scientists 71 D-Index: 40 scientists 72 D-Index: 50 scientists 73 D-Index: 46 scientists 74 D-Index: 43 scientists 75 D-Index: 45 scientists 76 D-Index: 45 scientists 77 D-Index: 30 scientists 78 D-Index: 25 scientists 79 D-Index: 31 scientists 80 D-Index: 29 scientists 81 D-Index: 18 scientists 82 D-Index: 21 scientists 83 D-Index: 26 scientists 84 D-Index: 15 scientists 85 D-Index: 15 scientists 86 D-Index: 19 scientists 87 D-Index: 19 scientists 88 D-Index: 12 scientists 89 D-Index: 7 scientists 90 D-Index: 19 scientists 91 D-Index: 20 scientists 92 D-Index: 13 scientists 93 D-Index: 9 scientists 94 D-Index: 13 scientists 95 D-Index: 8 scientists 96 D-Index: 7 scientists 97 D-Index: 6 scientists 98 D-Index: 6 scientists 99 D-Index: 6 scientists 100+ D-Index: 97 scientists
30 D-Index 100+

This scientist: 53 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 100 D-Index or more.

Overview

Nicholas Lintzeris is affiliated with the University of Sydney in Australia and has a significant research portfolio primarily in the field of Medicine. Their work encompasses several subfields, including Epidemiology, Public Health, Environmental and Occupational Health, Pharmacology, General Health Professions, and Pediatrics, Perinatology, and Child Health.

The main topics covered in their research include:

  • Substance Abuse Treatment and Outcomes
  • Opioid Use Disorder Treatment
  • Cannabis and Cannabinoid Research
  • Pain Management and Opioid Use
  • Prenatal Substance Exposure Effects
  • HIV, Drug Use, Sexual Risk
  • Homelessness and Social Issues

Several frequent collaborators have contributed to a substantial number of publications with Lintzeris, notably:

  • Adrian Dunlop (42 publications)
  • Llewellyn Mills (31 publications)
  • Nadine Ezard (21 publications)
  • Michael Farrell (21 publications)
  • Paul Haber (19 publications)

Their work has been published most often in the following venues:

  • Drug and Alcohol Review (20 publications)
  • Drug and Alcohol Dependence (6 publications)
  • International Journal of Drug Policy (6 publications)
  • BMJ Open (6 publications)
  • The Medical Journal of Australia (5 publications)

Some of the recent publications authored or co-authored by Nicholas Lintzeris include:

  • "Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic," 2020, Harm Reduction Journal
  • "Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review," 2020, CNS Drugs
  • "Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)," 2020, Harm Reduction Journal
  • "Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial," 2020, Annals of Oncology
  • "Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine," 2021, JAMA Network Open

Best Publications

  • Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.

    David J. Allsop;Jan Copeland;Nicholas Lintzeris;Adrian J. Dunlop

  • Opioid agonist treatment for pharmaceutical opioid dependent people.

    Suzanne Nielsen;Briony K Larance;Louisa Degenhardt;Linda Gowing

  • Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction

    John Strang;Teodora Groshkova;Teodora Groshkova;Ambros Uchtenhagen;Wim van den Brink

  • Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic.

    Adrian Dunlop;Buddhima Lokuge;Debbie Masters;Marcia Sequeira

  • Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis

    Suzanne Nielsen;Pamela Sabioni;Jose M Trigo;Mark A Ware

  • Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial

    John Strang;John Strang;Nicola Metrebian;Nicholas Lintzeris;Nicholas Lintzeris;Nicholas Lintzeris;Laura Potts

  • Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study

    Gabrielle Campbell;Wayne Hall;Wayne Hall;Amy Peacock;Nicholas Lintzeris

  • Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition

    Thomas R. Arkell;Nicholas Lintzeris;Richard C. Kevin;Johannes G. Ramaekers

  • Guidelines for the treatment of alcohol problems.

    Paul Haber;Nicholas Lintzeris;Elizabeth Proude;Olga Lopatko

  • Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review

    Krista J. Siefried;Krista J. Siefried;Liam S. Acheson;Nicholas Lintzeris;Nadine Ezard

  • Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non‐adherence and aberrant medication‐related behaviours

    Briony Larance;Louisa Degenhardt;Louisa Degenhardt;Nick Lintzeris;Adam Winstock

  • Experience of adjunctive cannabis use for chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study.

    Louisa Degenhardt;Louisa Degenhardt;Nicholas Lintzeris;Gabrielle Campbell;Raimondo Bruno;Raimondo Bruno

  • Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

    P. Grimison;A. Mersiades;A. Kirby;N. Lintzeris

  • Benzodiazepine Use among Chronic Pain Patients Prescribed Opioids: Associations with Pain, Physical and Mental Health, and Health Service Utilization

    Suzanne Nielsen;Nicholas Lintzeris;Raimondo Bruno;Raimondo Bruno;Gabrielle Campbell

  • A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal.

    Nicholas Lintzeris;James Bell;Gabriele Bammer;Damien J. Jolley

  • Benzodiazepines, methadone and buprenorphine: Interactions and clinical management

    Nicholas Lintzeris;Suzanne Nielsen

  • Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)

    Nicholas Lintzeris;Llewellyn Mills;Anastasia Suraev;Maria Bravo

  • The Pain and Opioids in Treatment study: Characteristics of a cohort using opioids to manage chronic non-cancer pain

    Gabrielle Campbell;Suzanne Nielsen;Raimondo Bruno;Raimondo Bruno;Nicholas Lintzeris

  • Unplanned pregnancy and contraceptive use in women attending drug treatment services.

    Kirsten I. Black;Christine Stephens;Paul S. Haber;Nicholas Lintzeris

  • Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) Cohort.

    Gabrielle Campbell;Suzanne Nielsen;Briony Larance;Raimondo Bruno

  • Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings

    Anni Ryan;Jennifer Holmes;Vi Hunt;Adrian Dunlop

  • A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial

    Amy E Gibson;Christopher M Doran;James R Bell;Anni Ryan

Frequent Co-Authors

Raimondo Bruno
Raimondo Bruno University of Tasmania
Louisa Degenhardt
Louisa Degenhardt University of New South Wales
Wayne Hall
Wayne Hall University of Queensland
Iain S. McGregor
Iain S. McGregor University of Sydney
Michael Farrell
Michael Farrell University of New South Wales
John Strang
John Strang King's College London
Jimmy D. Bell
Jimmy D. Bell University of Westminster
Mark Stoove
Mark Stoove Burnet Institute
John Attia
John Attia University of Newcastle Australia
Brian Draper
Brian Draper University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in Social Sciences and Humanities, a range of flexible online degrees are available to help you reach your career goals. Students can start with an accredited online psychology degree, which is ideal for those interested in human behavior, counseling, or research paths.

For those wanting to advance into specialized roles, graduate-level online programs offer practical options. Aspiring social workers may benefit from the flexibility of an online master's in social work, designed to accommodate busy schedules while preparing for licensure and a variety of impactful careers.

Students targeting clinical psychology can choose from the shortest online psyd programs, where they can earn advanced credentials and gain direct client experience. Meanwhile, if your focus is on family systems and therapy, several reputable mft online programs help prepare graduates for marriage and family therapist licensure.

These accredited online pathways offer flexibility, affordability, and a direct route to professional roles in counseling, mental health, and social services—empowering students to make a positive difference in their communities.

Best Scientists Citing Nicholas Lintzeris

Trending Scientists

Recently Published Articles